Financials

  • Market Capitalization 20.6 M
  • Employee 18
  • Founded 2020
  • CEO N/A
  • Website www.tevogen.com
  • Headquarter Delaware, United States
  • FIGI BBG013395405
  • Industry Biotechnologies
Chiffre d'affaires total
Résultat net
Bénéfice par action de base (BPA de base)
Dette totale
Flux de trésorerie disponible
Trésorerie et équivalents de trésorerie
ratio cours/bénéfice
-0.7
ratio cours/chiffre d'affaires
-66.55

Related tickers

#NomPrix24h %7 jours %1M %1 an %Cap Boursière7 Derniers Jours
4583
KZIA
Kazia Therapeutics Limited - American Depositary Shares
13.70 USD+1.71%+5.63%-4.20%+134.19%22.18 M USD
4589
SKYE
Skye Bioscience, Inc. - Common Stock
0.62 USD0.00%-12.68%-11.43%-22.50%21.79 M USD
4600
CLRB
Cellectar Biosciences, Inc. - Common Stock
2.60 USD-1.14%-2.62%+10.64%-17.20%20.78 M USD
4608
ATOS
Atossa Therapeutics, Inc. - Common Stock
2.37 USD+4.87%-2.87%+0.42%+160.44%20.41 M USD

Nouvelles